Infamous 'pharma bro' Martin Shkreli resigns from Turing Pharmaceuticals
The factors that led to Mr Shkreli's arrest Thursday had nothing to do with Turing, but a previous biotech company, Retrophin. Mr Shkreli founded that company in 2011, and was replaced by its board of directors last year. According to federal prosecutors, he lied to investors and used transactions at Retrophin to cover bad bets at his hedge funds.
No comments:
Post a Comment